Samsung’s enterprise funding unit is trying to spend money on California-based medical machine startup, Exo, in a spherical that would climb to $100 million, Bloomberg reported, citing nameless sources.
The spherical is being led by Sands Capital, Daring Capital and Qubit Well being Capital, the report stated, including that Qubit’s chairman, Imar Ishrak, would be a part of Exo’s board.
Based in 2015, Exo makes handheld medical imaging gadgets that use a mix of synthetic intelligence, medical imaging and silicon know-how for ultrasound examinations like scanning lungs or echocardiograms. The machine plugs right into a smartphone, and health workers can scan sufferers, doc, and share examination reviews utilizing one app.
The corporate has to date raised greater than $320 million in funding from buyers together with RA Capital Administration, BlackRock, Sands Capital, Intel, Sony, and Avidity Companions. The corporate most lately raised a $220 million in Sequence C spherical in 2021.
Exo can be in talks to accomplice with Samsung Medison Co., which makes medical gadgets for ultrasound diagnostics and digital X-ray programs, the report stated.
Exo, Samsung, Sands Capital, Daring Capital and Qubit Well being didn’t instantly return requests for remark.
{content material}
Supply: {feed_title}
